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Dear Editor
We read with interest the article by Nicolai et al.1
who described four children with Dravet syndrome
treated with valproic acid (VPA) and topiramate
(TPM), who all developed transient hepatic injury
shortly after introduction of acetaminophen in ther-
apeutic dosage. Based on the time interval between
fever, administration of acetaminophen, epileptic
status and liver enzyme disturbances, the authors
suggested that the accumulation of toxic acetami-
nophen metabolites due to inhibition of cytochrome
P450 enzymes by VPA and TPM was possibly respon-
sible for the hepatotoxicity.
We would like to report a similar observation in a
7-year-old girl with Dravet syndrome, who had been
on a stable AED regimen of VPA, clobazam and
stiripentol for some years. She was admitted after
being found by the parents with high fever and sopor
which was considered to be due to a postictal state.
She was treated with therapeutic dosage of acet-
aminophen (75 mg/kg/day) to suppress fever.
Within 12 h after initiation of acetaminophen ther-
apy, clotting parameters became progressively
abnormal (PT 21 s (n < 13 s), APTT 39 s (n < 33 s))
with other liver parameters remaining within nor-
mal range except for slightly elevated ASAT (120 U/
l). Twenty-four hours after initiation of acetamino-
phen biochemical analyses showed LDH 784 U/l,
ASAT 1580 U/l, ALAT 372 U/l, total bilirubin
4 mmol/l, albumin 26 g/l, NH3 60 mmol/l, PT 24 s
and APTT 42 s. Creatine kinase was also strongly
elevated (3354 U/l, n < 50 U/l). Because of suspi-
cion of acetaminophen toxicity, n-acetylcysteine
was given twice, even though serum acetaminophen
level appeared to be within the therapeutic range
(11 mg/l), and acetaminophen was discontinued.
Biochemical parameters started to recover withinDOI of original article: 10.1016/j.seizure.2007.07.003.
1059-1311/$ — see front matter # 2008 British Epilepsy Association
doi:10.1016/j.seizure.2008.02.0091 day after discontinuation of acetaminophen and
returned to normal within 1 week. Analysis of car-
nitine profile showed a carnitine deficiency (total
carnitine 20 mmol/l (n = 35—70 mmol/l), free carni-
tine 15 mmol/l (n = 25—55 mmol/l)).
This girl developed acute hepatotoxicity with pro-
nounced synthetic dysfunction resulting in disturbed
clotting and low protein values within 12—24 h after
introduction of acetaminophen, similar to the cases
described byNicolai et al. Our patient does, however,
show some important differences. First, she usedVPA
togetherwith stiripentol insteadofTPM,whichwould
indicate that neither of these two last drugs is criti-
cally involved in the hepatotoxicity. Obviously, stir-
ipentol was not capable of preventing the liver
problem, which is in contrast to the observation that
it is protective against acetaminophen-induced liver
necrosis in rats through inhibitionof cytochromes 1A2
and 3A4.2 Second, low carnitine concentrations were
identified in our patient that might be secondary to
long-termuseofVPA.VPA-inducedhepatic failure has
been related to carnitine deficiency. Third, in our
patient at least part of the elevated transaminases
seem to be related to rhabdomyolysis whichmight be
secondary to previously occurring epileptic seizures
and the carnitine deficiency.
Although it is unclear whether the hepatotoxicity
in our case is primarily due to the VPA and low
carnitine levels, the introduction of acetamino-
phen, or a combination of these, the observations
by Nicolai and ourselves indicate that the use of
acetaminophen in children with Dravet syndrome
who are on valproic acid therapy may induce acute
hepatic injury.Reference
1. Nicolai J. Acute hepatic injury in four children with Dravet
syndrome: valproic acid, topiramate or acetaminophen? Sei-
zure 2008;17:92—7.. Published by Elsevier Ltd. All rights reserved.
478 Letter to the editor2. Tran A. Protective effect of stiripentol on acetaminophen-
induced hepatotoxicity in rat. Toxicol Appl Pharmacol
2001;170:145—52.
Joanne F. Goorhuis,*
Department of Pediatrics,
Division of Intensive Care,
Beatrix Children’s Hospital,
University Medical Center Groningen,
University of Groningen,
Hanzeplein 1, 9700 RB Groningen,
The Netherlands
Henkjan J. Verkade
Department of Pediatrics,
Division of Gastroenterology,
Beatrix Children’s Hospital,
University Medical Center Groningen,University of Groningen, Hanzeplein 1,
9700 RB Groningen, The Netherlands
Oebo F. Brouwer
Department of Neurology,
Division of Pediatric Neurology,
Beatrix Children’s Hospital,
University Medical Center Groningen,
University of Groningen, Hanzeplein 1,
9700 RB Groningen, The Netherlands
*Corresponding author. Tel.: +31 50 3612748
E-mail address: j.f.goorhuis@bkk.umcg.nl
(J.F. Goorhuis)
19 November 2007
